Suchergebnisse - "Ainai, Akira"

PubPharm (123)

1

Viral load and timing of infection define neutralization diversity to SARS-CoV-2 infection

enthalten in: bioRxiv.org | 2024

von Miyamoto, S. | Arashiro, T. | Ueno, A. | +16

2

Estimating serum cross-neutralizing responses to SARS-CoV-2 Omicron sub-lineages elicited by pre-Omicron or Omicron breakthrough infection with exposure interval compensation modeling

enthalten in: bioRxiv.org | 2024

von Miyamoto, S. | Kuroda, Y. | Kanno, T. | +19

3

Diverse pro-inflammatory ability of mutated spike protein derived from variant strains of SARS-CoV-2

enthalten in: Cytokine | 2024

von Kawata, D. | Iwai, H. | Oba, S. | +8

4

Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire

enthalten in: Journal of virology | 2024

von Shingai, M. | Iida, S. | Kawai, N. | +14

5

Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults

enthalten in: NEJM evidence | 2024

von Morino, E. | Mine, S. | Tomita, N. | +37

6

Author Correction : Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice

enthalten in: Scientific reports | 2024

von Homma, T. | Nagata, N. | Hashimoto, M. | +22

ErratumFor: Sci Rep. 2022 Dec 2;12(1):20861. - PMID 36460696

7

Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Miyamoto, S. | Nishiyama, T. | Ueno, A. | +39

8

Apple-shaped obesity : A risky soil for cytokine-accelerated severity in COVID-19

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Hosoya, T. | Oba, S. | Komiya, Y. | +19

9

Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2 : Implications for vaccine dose interval

enthalten in: iScience | 2023

von Miyamoto, S. | Kuroda, Y. | Kanno, T. | +19

10

Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults

enthalten in: Vaccine | 2023

von Sonoyama, T. | Iwata, S. | Shinkai, M. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]